Expert Opinion on Pharmacotherapy, Volume 2, Issue 9 (2001)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Pharmacotherapy, Volume 2, Issue 9 (2001)

See all volumes and issues
Vol 25, 2024 Vol 24, 2023 Vol 23, 2022 Vol 22, 2021 Vol 21, 2020 Vol 20, 2019 Vol 19, 2018 Vol 18, 2017 Vol 17, 2016 Vol 16, 2015 Vol 15, 2014 Vol 14, 2013 Vol 13, 2012 Vol 12, 2011 Vol 11, 2010 Vol 10, 2009 Vol 9, 2008 Vol 8, 2007 Vol 7, 2006 Vol 6, 2005 Vol 5, 2004 Vol 4, 2003 Vol 3, 2002 Volume 2, 2001 Vol 1, 1999-2000
Download citations Download PDFs Download issue

Miscellaneous

Therapy of Graves’ ophthalmopathy: a novel application of somatostatin analogues
Juan J Díez
Pages: 1361-1365
Published online: 25 Feb 2005
First Page PreviewforTherapy of Graves’ ophthalmopathy: a novel application of somatostatin analogues | References | PDF (85.3 KB)
  • 30 Views
  • 3 CrossRef citations
  • 0Altmetric
Oral contraceptives and mood
Linda S Kahn & Uriel Halbreich
Pages: 1367-1382
Published online: 25 Feb 2005
AbstractforOral contraceptives and mood | References | PDF (252.9 KB)
  • 457 Views
  • 31 CrossRef citations
  • 0Altmetric
Mifepristone: a potential postcoital contraceptive
Pak Chung Ho
Pages: 1383-1388
Published online: 25 Feb 2005
AbstractforMifepristone: a potential postcoital contraceptive | References | PDF (104.5 KB)
  • 47 Views
  • 8 CrossRef citations
  • 0Altmetric
Male hormonal contraceptives
John K Amory & Bradley D Anawalt
Pages: 1389-1398
Published online: 25 Feb 2005
AbstractforMale hormonal contraceptives | References | PDF (150.3 KB)
  • 101 Views
  • 2 CrossRef citations
  • 0Altmetric
Tamoxifen and the female reproductive tract
Sharon L Mount & Gamal H Eltabbakh
Pages: 1399-1413
Published online: 25 Feb 2005
AbstractforTamoxifen and the female reproductive tract | References | PDF (6.5 MB)
  • 66 Views
  • 5 CrossRef citations
  • 0Altmetric
Primary Sjögren’s syndrome: oral aspects on pathogenesis, diagnostic criteria, clinical features and approaches for therapy
Birgitte Nauntofte & Anne Marie Pedersen
Pages: 1415-1436
Published online: 25 Feb 2005
AbstractforPrimary Sjögren’s syndrome: oral aspects on pathogenesis, diagnostic criteria, clinical features and approaches for therapy | References | PDF (411.2 KB)
  • 147 Views
  • 17 CrossRef citations
  • 0Altmetric
Recent developments in the management of haemophagocytic lymphohistiocytosis
Tomoko Teramura, Akira Morimoto, Shinsaku Imashuku & Shigeyoshi Hibi
Pages: 1437-1448
Published online: 25 Feb 2005
AbstractforRecent developments in the management of haemophagocytic lymphohistiocytosis | References | PDF (175.6 KB)
  • 202 Views
  • 33 CrossRef citations
  • 0Altmetric
Homocysteine-lowering treatment: an overview
Coen DA Stehouwer & Coen van Guldener
Pages: 1449-1460
Published online: 25 Feb 2005
AbstractforHomocysteine-lowering treatment: an overview | References | PDF (202.3 KB)
  • 136 Views
  • 34 CrossRef citations
  • 0Altmetric
Update on alendronate for osteoporosis: once-weekly dosing
Thomas J Schnitzer
Pages: 1461-1472
Published online: 25 Feb 2005
AbstractforUpdate on alendronate for osteoporosis: once-weekly dosing | References | PDF (163.8 KB)
  • 94 Views
  • 12 CrossRef citations
  • 0Altmetric
Zinc acetate for the treatment of Wilson’s disease
George J Brewer
Pages: 1473-1477
Published online: 25 Feb 2005
AbstractforZinc acetate for the treatment of Wilson’s disease | References | PDF (92.2 KB)
  • 469 Views
  • 83 CrossRef citations
  • 0Altmetric
Calfactant
Doug Willson
Pages: 1479-1493
Published online: 25 Feb 2005
AbstractforCalfactant | References | PDF (235.9 KB)
  • 58 Views
  • 7 CrossRef citations
  • 0Altmetric
Oral uracil-tegafur: an alternative to intravenous 5-fluorouracil?
Chris Twelves & Rob Jones
Pages: 1495-1505
Published online: 25 Feb 2005
AbstractforOral uracil-tegafur: an alternative to intravenous 5-fluorouracil? | References | PDF (163.9 KB)
  • 46 Views
  • 7 CrossRef citations
  • 0Altmetric
ReoPro rules: results from the ‘Do Tirofiban and ReoPro Give Similar Efficacy Trial’ (TARGET)
Sheila A Doggrell
Pages: 1507-1509
Published online: 25 Feb 2005
AbstractforReoPro rules: results from the ‘Do Tirofiban and ReoPro Give Similar Efficacy Trial’ (TARGET) | References | PDF (56.9 KB)
  • 28 Views
  • 2 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Advances with janus kinase inhibitors for the treatment of myeloproliferative neoplasms: an update of the literature
Anthony M. Hunter et al.
Review Article | Published online: 27 Jul 2024
PSMA-based therapeutics for prostate cancer
Panagiotis Velissarios Stamatakos et al.
Review Article | Published online: 26 Jul 2024
Examining linaclotide for the treatment of chronic idiopathic constipation
Jeff Angelo Taclob et al.
Review Article | Published online: 26 Jul 2024
What is the impact of anemia pharmacotherapy on chronic kidney disease progression?
Hanna T. Webb et al.
Editorial | Published online: 24 Jul 2024
Free Access
View all latest articles